The Need for Transparency in Medical AI

The adoption of artificial intelligence (AI) in healthcare and biomedical research is intrinsically linked to the trustworthiness and transparency of these systems. Recent advancements in deep research systems aim to accelerate evidence-grounded scientific discovery by integrating AI agents with multi-hop information retrieval, reasoning, and synthesis capabilities. However, most existing solutions exhibit a significant gap: the lack of explicit and inspectable criteria for evidence appraisal.

This deficiency can lead to compounding errors and makes it challenging for researchers and clinicians to assess the reliability of the generated outputs. Concurrently, existing benchmark approaches rarely evaluate performance on complex, real-world medical questions, leaving a gap between the theoretical capabilities of AI and its practical applicability.

DeepER-Med: An Agentic Framework for Research

In this context, DeepER-Med has been introduced as a Deep Evidence-based Research framework specifically designed for medicine, integrating an agentic AI system. DeepER-Med frames deep medical research as an explicit and inspectable workflow for evidence generation. This approach is crucial for ensuring transparency and verifiability, which are essential elements for clinical acceptance.

The framework is structured into three main modules: research planning, agentic collaboration, and evidence synthesis. This subdivision allows for systematic management of each phase of the research process, from formulating questions to gathering and analyzing information, and finally to presenting conclusions supported by clear evidence.

Evaluation and Clinical Impact

To support a realistic evaluation of its capabilities, the DeepER-MedQA evidence-grounded dataset was also developed. This dataset comprises 100 expert-level research questions, derived from authentic medical research scenarios and curated by a multidisciplinary panel of 11 biomedical experts. The creation of such a specific dataset, curated by specialists, is essential for measuring AI's effectiveness in complex clinical contexts.

Expert manual evaluation demonstrated that DeepER-Med consistently outperforms widely used production-grade platforms across multiple criteria, including the generation of novel scientific insights. DeepER-Med's practical utility was further demonstrated through eight real-world clinical cases. Human clinician assessment indicated that DeepER-Med's conclusions align with clinical recommendations in seven of these cases, highlighting its potential for medical research and decision support.

Deployment Considerations and Data Sovereignty

The introduction of advanced AI systems like DeepER-Med into the healthcare sector raises important questions regarding their deployment. For healthcare organizations evaluating the implementation of such frameworks, the choice between self-hosted infrastructures and cloud solutions involves significant trade-offs. Aspects such as data sovereignty, regulatory compliance (e.g., GDPR), and security in air-gapped environments become paramount, given the extremely sensitive nature of medical information.

DeepER-Med's ability to offer an explicit and inspectable workflow is a notable advantage in regulated contexts, where the traceability and justifiability of AI decisions are fundamental. This approach can reduce the overall TCO by mitigating legal and operational risks associated with managing sensitive data, and by strengthening trust in AI as a critical decision support tool. AI-RADAR offers analytical frameworks on /llm-onpremise to evaluate these trade-offs, providing valuable support for deployment decisions.